-
Study aim
-
Determination of the effect of vitamin E and C supplements on risk factors of coronary artery disease (CAD) in patients with coronary heart disease
-
Design
-
In this clinical trial with a factorial design, the patients will be allocated to four groups of control, vitamin C, vitamin E and combination by permutation blocks. The groups will be matched in terms of confounding variables such as occupation, education, age, gender, diabetes, physical activity, drugs that affect blood lipids and glucose, blood lipids and glucose levels, blood pressure, BMI and CRP.
-
Settings and conduct
-
The research area will be the specialized heart clinic of Jawad Al-Aimeh and Razavi hospitals in Mashhad. After obtaining informed consent from patients, explaining the goals of the plan for them, if they have inclusion criteria, after 15 minutes of rest, the systolic and diastolic blood pressure of the patient and then the height and weight will be measured. Then everyone after 8-12 hours of fasting during the night and a blood sample to check FBS, lipid profile and CRP will be sent to the laboratory. After grouping the patients and implementation of the intervention, again, the outcome variables will be measured in all patients at the end of the study.
-
Participants/Inclusion and exclusion criteria
-
All patients who are willing to participate in the study have entry requirements in terms of inclusion criteria.
-
Intervention groups
-
In the control group, no supplement will be given and only routine care will be provided. In other groups, in addition to routine care, separately in group of vitamin C, 1,000 mg of vitamin C for 10 weeks, in vitamin E, 600 mg of vitamin E for 10 weeks, in combination, daily 1000 mg of vitamin C and 600 mg of vitamin E for 10 weeks will be prescribed by your doctor.
-
Main outcome variables
-
Systolic and diastolic blood pressure, lipid profiles, FBS, BMI and CRP